π
|
Toll-like receptor 4 signaling augments transforming growth factor-Ξ² responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.
14 auth.
S. Bhattacharyya,
Kathleen Kelley,
D. Melichian,
Z. Tamaki,
Feng Fang,
Yunyun Su,
G. Feng,
R. Pope,
G. R. Budinger,
G. Mutlu,
...
R. Lafyatis,
T. Radstake,
C. Feghali-Bostwick,
J. Varga
|
7 |
2013 |
7 π
|
π
|
Tenascin-C drives persistence of organ fibrosis
15 auth.
S. Bhattacharyya,
Wenxia Wang,
Luisa Morales-Nebreda,
G. Feng,
Minghua Wu,
Xiaodong Zhou,
R. Lafyatis,
J. Lee,
M. Hinchcliff,
C. Feghali-Bostwick,
...
K. Lakota,
G. R. Budinger,
Kirtee Raparia,
Z. Tamaki,
J. Varga
|
7 |
2016 |
7 π
|
π
|
FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
8 auth.
S. Bhattacharyya,
Z. Tamaki,
Wenxia Wang,
M. Hinchcliff,
Paul J. Hoover,
S. Getsios,
...
E. White,
J. Varga
|
7 |
2014 |
7 π
|
π
|
Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis
16 auth.
M. Hinchcliff,
Chiang-Ching Huang,
Tammara A. Wood,
J. M. Mahoney,
V. Martyanov,
S. Bhattacharyya,
Z. Tamaki,
J. Lee,
M. Carns,
Sofia Podlusky,
...
Arlene Sirajuddin,
Sanjiv J. Shah,
R. Chang,
R. Lafyatis,
J. Varga,
M. Whitfield
|
7 |
2013 |
7 π
|
π
|
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
10 auth.
Feng Fang,
Lei Liu,
Yang Yang,
Z. Tamaki,
Jun Wei,
R. Marangoni,
...
S. Bhattacharyya,
R. Summer,
B. Ye,
J. Varga
|
6 |
2012 |
6 π
|
π
|
TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
13 auth.
S. Bhattacharyya,
Wenxia Wang,
W. Qin,
K. Cheng,
Sara K Coulup,
Sherry A Chavez,
Shuangshang Jiang,
Kirtee Raparia,
LΓΊcia de Almeida,
C. Stehlik,
...
Z. Tamaki,
H. Yin,
J. Varga
|
6 |
2018 |
6 π
|
π
|
A synthetic PPAR-Ξ³ agonist triterpenoid ameliorates experimental fibrosis: PPAR-Ξ³-independent suppression of fibrotic responses
11 auth.
Jun Wei,
Hongyan Zhu,
K. Komura,
Gabriel Lord,
M. TomΔΓk,
Wenxia Wang,
...
Sruthi Doniparthi,
Z. Tamaki,
M. Hinchcliff,
J. Distler,
J. Varga
|
6 |
2013 |
6 π
|
π
|
Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis
12 auth.
Y. Masui,
Y. Asano,
S. Shibata,
S. Noda,
N. Aozasa,
K. Akamata,
...
Daisuke Yamada,
Z. Tamaki,
Y. Tada,
M. Sugaya,
S. Sato,
Takafumi Kadono
|
5 |
2012 |
5 π
|
π
|
Serum Levels of Galectin-3: Possible Association with Fibrosis, Aberrant Angiogenesis, and Immune Activation in Patients with Systemic Sclerosis
14 auth.
Takashi Taniguchi,
Y. Asano,
K. Akamata,
S. Noda,
Y. Masui,
D. Yamada,
Takehiro Takahashi,
Y. Ichimura,
T. Toyama,
Z. Tamaki,
...
Y. Tada,
M. Sugaya,
T. Kadono,
S. Sato
|
5 |
2012 |
5 π
|
π
|
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
8 auth.
S. Bhattacharyya,
Wenxia Wang,
Z. Tamaki,
Bo Shi,
A. Yeldandi,
Y. Tsukimi,
...
M. Yamasaki,
J. Varga
|
5 |
2018 |
5 π
|